Patton Receives RO1 Grant from NIH for Home Based Telemedicine to Reduce Hypoglycemia Fear in Parents of Young Children
Susana Patton, PhD, was recently awarded a five-year, $3,074,783 R01 grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
Dr. Patton’s “Home video-based telemedicine to reduce hypoglycemia fear in parents of young children” study will focus on reducing family fear of hypoglycemia in young children with type 1 diabetes. The project will expand upon Dr. Patton’s previous telemedicine intervention, REDCHiP (Reducing Emotional Distress for Childhood Hypoglycemia in Parents). It will address the two main components that accompany Fear of Hypoglycemia: impaired quality of life and compensatory behaviors that raise children’s blood glucose levels leading to ongoing poor metabolic control (HbA1c) and an increased risk for long-term vascular complications.
The objective of this R01 is to conduct a randomized clinical trial comparing REDCHiP to a relevant attention control intervention (ATTN) in families of young children, thereby continuing to establish its efficacy. The project will evaluate whether parents who receive REDCHiP report reductions in hypoglycemia fear and parenting stress at post-treatment compared to parents who receive the ATTN and whether children of parents who receive REDCHiP have a lower HbA1c and less glycemic variability at post-treatment compared to children of parents who receive ATTN. Lastly, the project will examine for maintenance of improvements in hypoglycemia fear, parenting stress, and children’s HbA1c in a three-month follow-up.
Children’s Mercy has received a subaward for consortium activity that will be led by Mark Clements, MD, PhD, Endocrinology.
Dr. Clements is a Professor in Pediatrics at the University of Kansas Medical Center and a Community Physician with the Center for Children’s Healthy Lifestyles & Nutrition, a research partnership between Children’s Mercy and KU Medical Center. The Center is a centralized resource for community members, academic scholars and business leaders who are interested in arresting the current rates of childhood obesity and moving forward to ensure the healthy lifestyles and nutrition of all children.
Children’s Mercy Kansas City is an independent, non-profit, 390-bed pediatric health system, providing over half a million patient encounters each year for children from across the country. Children’s Mercy is ranked by U.S. News & World Report in all ten specialties. We have received Magnet® recognition five times for excellence in nursing services. In affiliation with the University of Missouri-Kansas City, our faculty of nearly 800 pediatric specialists and researchers is actively involved in clinical care, pediatric research and educating the next generation of pediatricians and pediatric subspecialists. The Children’s Mercy Research Institute (CMRI) integrates research and clinical care with nationally recognized expertise in genomic medicine, precision therapeutics, population health, health care innovation and emerging infections. In 2021 the CMRI moved into a nine-story, 375,000-square-foot space emphasizing a translational approach to research in which clinicians and researchers work together to accelerate the pace of discovery that enhances care.